IVERIC BIO/ US46583P1021 /
7/10/2023 10:01:14 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
39.95USD | - | 199,958 Turnover: 7.98 mill. |
-Bid Size: - | -Ask Size: - | 4.07 bill.USD | 0.00% | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||
---|---|---|---|---|---|---|---|
Property and Equipment | .2000 | .0300 | 1.9000 | ||||
Intangible Assets | - | - | - | ||||
Long-Term Investments | - | - | - | ||||
Fixed Assets | - | - | - | ||||
Inventories | - | - | - | ||||
Accounts Receivable | - | - | - | ||||
Cash and Cash Equivalents | 125.7000 | 66.4000 | 261.4000 | ||||
Current Assets | 128.6000 | 216.6000 | 387.5000 | ||||
Total Assets | 130.2000 | 216.8000 | 389.4000 |
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||
---|---|---|---|---|---|---|---|
Accounts Payable | - | - | - | ||||
Long-term debt | - | - | - | ||||
Liabilities to Banks | - | - | - | ||||
Provisions | - | - | - | ||||
Liabilities | 13 | 25.2000 | 28.8000 | ||||
Share Capital | .0500 | .0900 | .1150 | ||||
Total Equity | 117.2000 | 191.6000 | 360.5000 | ||||
Minority Interests | - | - | - | ||||
Total liabilities equity | 130.2000 | 216.8000 | 389.4000 |
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||
---|---|---|---|---|---|---|---|
Revenues | - | - | - | ||||
Depreciation (total) | - | - | - | ||||
Operating Result | -61.3000 | -88.7000 | -114.8000 | ||||
Interest Income | - | - | - | ||||
Income Before Taxes | -59 | -88.2000 | -114.5000 | ||||
Income Taxes | .1000 | 3.7000 | 0.0000 | ||||
Minority Interests Profit | - | - | - | ||||
Net Income | -58.9000 | -84.5000 | -114.5000 |
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||
---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -48.5000 | -66.1000 | -98.6000 | ||||
Cash Flow from Investing Activities | - | - | 21.3000 | ||||
Cash Flow from Financing | - | - | 272.3000 | ||||
Decrease / Increase in Cash | - | - | - | ||||
Employees | 38 | 57 | 37 |